We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Belluscura Plc | LSE:BELL | London | Ordinary Share | GB00BD3B8Z11 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.25 | 8.50 | 10.00 | 9.25 | 9.25 | 9.25 | 30,000 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 825k | -18.52M | -0.1100 | -0.84 | 15.58M |
Date | Subject | Author | Discuss |
---|---|---|---|
13/8/2021 09:00 | £100m market cap. | tarrant77 | |
13/8/2021 08:52 | Great climb this morning as more climb aboard. Good info buywell 😁 | moormoney | |
13/8/2021 08:10 | Good morning Hopefully this company will not be t/o by an American one but even if so, holders should be ok. Seem to be a larger number of trades earlier than usual. | maytrees | |
12/8/2021 23:25 | buywell posted about Belluscura months ago on the BUY thread Anyone reading those posts might have benefitted from what was an obvious winner POC's are going to take a big market share from olde O2 cylinders that weakened sick people have to drag around The Covid Delta variant is in the process of creating 'long COVID' patients These will be circa 30% of those that acquire it ( see BUY posts ) A large percentage of whom will need home oxygen therapy (circa 40% ditto) We are talking hundreds of millions of people here--- these mutant strains are not going away unless a technology gets used that kills the virus whilst it is airborne and politicians are dragging their feet on this issue Belluscura could easily now do a cash raise at 80p as their patented technology is imo vastly superior to what is currently being sold by much bigger v$ Billion dollar US based companies BELL itself could now be bought before it has chance to spread it's wings --- before it grabs meaningful market share A victim of its own success and superior technology --- these things happen Which is why Belluscura now need to put their foot on the Gas Raise more cash still and expand production to meet the coming exponential POC demnds --- plus other bigger concentrators to supply Hospital demands --- the tech is also good for such applications dyor | buywell3 | |
12/8/2021 22:15 | PUGUGLY - I take your point that it's got a fairly rich M/Cap for a Company with no sales as yet, but not sure how/where it's been over ramped. Of course there are competitors but I think (hope!) it is telling that Bell have managed to poach a key player from Inogen who are one of those in the market. High risk but if the product is as good as stated then it will have plenty of further upside. | tanners | |
12/8/2021 18:14 | Personal first awareness note at 84.5p MC £95M but seems too rich and over ramped. One to watch however. There are however a number of competitors already established. Neighbour bought one over 9 months ago. | pugugly | |
12/8/2021 18:02 | Good upward momentum in this stock as the market recognises the huge market opportunity that mobile oxygen represents worldwide. | aconceptisabrick | |
12/8/2021 09:54 | Some decent buys now though. | maytrees | |
12/8/2021 07:59 | Good morning SP up again on no news though most trades so far are reported as sells. | maytrees | |
10/8/2021 02:42 | POST REMOVED | buywell2 | |
09/8/2021 08:15 | Good morning 68.6p to sell at present. I assume that most trades so far are sells (not I!). | maytrees | |
07/8/2021 14:44 | Here are a few thoughts of mine on BELL: • Focused on chronic lung diseases, including long COVID, so demand should be resilient to the passing of the COVID-19 pandemic. • Great commitment to growth. • Great focus. • Advanced patented technology. • Great R&D pipeline. In conclusion, it looks to have great short, medium, & long term growth prospects potential. At 67.5p, market cap. £76.48 million, it seems to me a very attractive buy. | hedgehog 100 | |
02/8/2021 02:29 | BG, Whoops, didn't realise you were Paul hill (clue in the moniker didn't register clearly), so not actually a holder of BELL (or TEK) then? I must have been jumping to conclusions. I already follow your linked in account (and vox) but doubt my portflio would interest you (as no similarities) so won't post my (very amateur) youtube link. | travestor | |
01/8/2021 14:52 | Many thanks Travestor. FYI. these are my latest portfolio positions & L/T returns www.linkedin.com/pos | brummy_git | |
01/8/2021 05:30 | POST REMOVED | buywell2 | |
01/8/2021 01:54 | BG - and Paul Hill said he could see it hitting 180p plus, granted he is a holder, but I respect his comments (he does well despite the inane interruptions from his sidekick) | travestor | |
30/7/2021 14:13 | Belluscura was discussed here on today's Vox 'Stock Picking' videocast (starts 45:15). www.linkedin.com/pos | brummy_git | |
27/7/2021 08:43 | No sooner had I posted the above... | maytrees | |
27/7/2021 08:41 | Good morning buywell2 Little apparent interest so far in BELL shares though now up 7% | maytrees | |
27/7/2021 06:30 | POST REMOVED | buywell2 | |
23/7/2021 10:40 | Good morning Fair number of buy trades recently. | maytrees | |
18/7/2021 22:58 | One thing for sure is that with long COVID and Covid-19 continuance due to variants The World will need more and more oxygen --- for Hospitals and Home therapy use buywell wonders if something similar might happen as to what is happening regarding the provision of cheap testing kits for Covid-19 UK companies with good technology seem to attract attention One would imagine this could have ramifications/implic News Bill Gates and George Soros join buyout of UK Covid testing company One suspects that being a charity tests will be sold at cost The founder of Microsoft founder joined the Soros Economic Development Fund in a deal to buy UK based Mologic which has developed 10-minute Covid tests that it aims to make for as little as $1. | buywell3 | |
13/7/2021 06:26 | POST REMOVED | buywell2 | |
08/7/2021 15:49 | BELL looks to be on a great track. The positive news keeps coming ! | novandi | |
08/7/2021 09:08 | #BELL In a potentially exciting development, Belluscura said today that the US Centers for Medicare & Medicaid Services - responsible for c. 37% of the nation's healthcare spend - was looking to expand its medical insurance cover for in-home portable oxygen concentrators (POCs). The idea being to allow patients to further use these devices outside of hospital settings in order to free up scarce beds & capacity (re Covid). Instead treating sufferers of 'cluster headaches' and other acute conditions elsewhere. Clearly if approved, this could provide a major lift for Belluscura 's ultra-lightweight, modular POCs that treat patients with severe respiratory conditions, such as COPD, pneumonia & coronavirus. Particularly as its X-PLO2R DX Model is being 'hard-launched' in the first half of 2022. www.linkedin.com/pos | brummy_git |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions